Drugplain

Tretinoin Cream 1 mg/g

tretinoin · CREAM · Obagi Cosmeceuticals LLC

1 Recall on Record
Plain English

Tretinoin Cream is a cream containing tretinoin at 1 mg/g, taken topical. Manufactured by Obagi Cosmeceuticals LLC.

Key Facts

Brand Name
Tretinoin Cream
Generic Name
tretinoin
NDC Code (Product)
62032-417
Manufacturer
Obagi Cosmeceuticals LLC
Strength
1 mg/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
NDA017340
Drug Class
Retinoid [EPC]
Marketing Start
01/26/1973

Recall History

1 Recall on Record
Class II02/10/2017

Synergy Rx

Lack of Assurance of Sterility: There are also CGMP Deviations.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use816 reports
drug ineffective690 reports
product use in unapproved indication446 reports
pain443 reports
vomiting417 reports
paraesthesia341 reports
abdominal pain upper331 reports
nausea326 reports
rash320 reports
diarrhoea311 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Tretinoin is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Dosage & Administration

DOSAGE AND ADMINISTRATION Tretinoin Cream should be applied once a day, before retiring, to the skin where acne lesions appear, using enough to cover the entire affected area lightly. Application may cause a transitory feeling of warmth or slight stinging. In cases where it has been necessary to temporarily discontinue therapy or to reduce the frequency of application, therapy may be resumed or frequency of application increased when the patients become able to tolerate the treatment. Alterations of vehicle, drug concentration, or dose frequency should be closely monitored by careful observation of the clinical therapeutic response and skin tolerance. During the early weeks of therapy, an apparent exacerbation of inflammatory lesions may occur. This is due to the action of the medication on deep, previously unseen lesions and should not be considered a reason to discontinue therapy. Therapeutic results should be noticed after 2 to 3 weeks but more than 6 weeks of therapy may be required before definite beneficial effects are seen. Once the acne lesions have responded satisfactorily, it may be possible to maintain the improvement with less frequent applications, or other dosage form

Contraindications

CONTRAINDICATIONS Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

Drug Interactions

Drug Interactions Concomitant topical medication, medicated or abrasive soaps and cleansers, soaps and cosmetics that have a strong drying effect, and products with high concentrations of alcohol, astringents, spices or lime should be used with caution because of possible interaction with tretinoin. Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin. It also is advisable to “rest” a patient’s skin until the effects of such preparations subside before use of tretinoin is begun.

Adverse Reactions

ADVERSE REACTIONS The skin of certain sensitive individuals may become excessively red, edematous, blistered, or crusted. If these effects occur, the medication should either be discontinued until the integrity of the skin is restored, or the medication should be adjusted to a level the patient can tolerate. True contact allergy to topical tretinoin is rarely encountered. Temporary hyper- or hypopigmentation has been reported with repeated application of tretinoin. Some individuals have been reported to have heightened susceptibility to sunlight while under treatment with tretinoin. To date, all adverse effects of tretinoin have been reversible upon discontinuance of therapy (see DOSAGE AND ADMINISTRATION). To report SUSPECTED ADVERSE REACTIONS, contact Obagi Cosmeceuticals LLC at 1-800-636-7546 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Frequently Asked Questions

What is Tretinoin Cream used for?

Tretinoin Cream contains tretinoin. It is a cream taken topical. Consult your doctor for specific uses.

Is Tretinoin Cream a controlled substance?

Tretinoin Cream is not classified as a controlled substance by the DEA.

What is the generic name for Tretinoin Cream?

The generic name for Tretinoin Cream is tretinoin. There are 12 other brand versions of tretinoin.

What is the NDC code for Tretinoin Cream 1 mg/g?

The NDC (National Drug Code) for Tretinoin Cream 1 mg/g is 62032-417, listed by Obagi Cosmeceuticals LLC.

Product NDC

62032-417

Package NDC

62032-417-20

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)